We are live on ! Find out more
MTNB icon

Matinas BioPharma

66 hedge funds and large institutions have $33.5M invested in Matinas BioPharma in 2021 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 20 increasing their positions, 8 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 8

8% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 13

0% more funds holding

Funds holding: 66 → 66 (0)

6.48% less ownership

Funds ownership: 18.47% → 11.99% (-6.5%)

74% less capital inflows, than outflows

Capital inflows: $3.15M | Capital outflows: $12.3M

Holders
66
Holders Change
–
Holders Change %
0%
% of All Funds
1.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
20
Reduced
8
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

MTNB Hedge Fund Activity: Q3 2021 in Review

66 of the 5,730 institutional investors tracked by Wall St. Rank reported a position in Matinas BioPharma (MTNB) for Q3 2021, worth a combined $33.5M — up 14% from $29.2M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new MTNB positions and 13 closed out — a net gain of 1 holder — while 20 added to existing stakes and 8 trimmed.

The largest buyer was Sargent Investment Group, adding an estimated $907K. The largest seller was Boxer Capital Management, exiting entirely with an estimated $8.9M sold.

  • 66 institutional investors held Matinas BioPharma (MTNB) as of Q3 2021, unchanged from Q2 2021.
  • Funds reported $33.5M of Matinas BioPharma stock for Q3 2021, up 14% quarter-over-quarter.
  • 14 funds opened new Matinas BioPharma positions in Q3 2021 and 13 closed out, a net change of +1 holder.
  • The largest Matinas BioPharma buyer in Q3 2021 was Sargent Investment Group, an estimated $907K added.
  • The largest Matinas BioPharma seller in Q3 2021 was Boxer Capital Management, an estimated $8.9M sold.

Based on aggregated 13F filings for Q3 2021.